Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
- PMID: 24104550
- DOI: 10.1093/carcin/bgt333
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
Abstract
MicroRNAs (miRNAs) are endogenous non-coding RNAs, which play an essential role in the regulation of gene expression during carcinogenesis. The role of miRNAs in breast cancer has been thoroughly investigated, and although many miRNAs are identified as cancer related, little is known about their involvement in benign tumors. In this study, we investigated miRNA expression profiles in the two most common types of human benign tumors (fibroadenoma/fibroadenomatosis) and in malignant breast tumors and explored their role as oncomirs and tumor suppressor miRNAs. Here, we identified 33 miRNAs with similar deregulated expression in both benign and malignant tumors compared with the expression levels of those in normal tissue, including breast cancer-related miRNAs such as let-7, miR-21 and miR-155. Additionally, messenger RNA (mRNA) expression profiles were obtained for some of the same samples. Using integrated mRNA/miRNA expression analysis, we observed that overexpression of certain miRNAs co-occurred with a significant downregulation of their candidate target mRNAs in both benign and malignant tumors. In support of these findings, in vitro functional screening of the downregulated miRNAs in non-malignant and breast cancer cell lines identified several possible tumor suppressor miRNAs, including miR-193b, miR-193a-3p, miR-126, miR-134, miR-132, miR-486-5p, miR-886-3p, miR-195 and miR-497, showing reduced growth when re-expressed in cancer cells. The finding of deregulated expression of oncomirs and tumor suppressor miRNAs in benign breast tumors is intriguing, indicating that they may play a role in proliferation. A role of cancer-related miRNAs in the early phases of carcinogenesis and malignant transformation can, therefore, not be ruled out.
Similar articles
-
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18. Gene. 2017. PMID: 27998789
-
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669. Genes Chromosomes Cancer. 2009. PMID: 19396864
-
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256. Hepatology. 2008. PMID: 18433021
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
MicroRNA involvement in the pathogenesis and management of breast cancer.J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. J Clin Pathol. 2009. PMID: 19398594 Review.
Cited by
-
nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.Oncotarget. 2016 Nov 15;7(46):75000-75012. doi: 10.18632/oncotarget.11852. Oncotarget. 2016. PMID: 27612419 Free PMC article.
-
MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.Cancer Sci. 2019 Oct;110(10):3098-3109. doi: 10.1111/cas.14164. Epub 2019 Aug 19. Cancer Sci. 2019. PMID: 31389121 Free PMC article.
-
Non-coding 886 (nc886/vtRNA2-1), the epigenetic odd duck - implications for future studies.Epigenetics. 2024 Dec;19(1):2332819. doi: 10.1080/15592294.2024.2332819. Epub 2024 Mar 25. Epigenetics. 2024. PMID: 38525792 Free PMC article. Review.
-
Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.Am J Transl Res. 2017 Jun 15;9(6):2852-2864. eCollection 2017. Am J Transl Res. 2017. PMID: 28670374 Free PMC article.
-
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.Genome Med. 2021 Apr 29;13(1):72. doi: 10.1186/s13073-021-00880-4. Genome Med. 2021. PMID: 33926515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical